share_log

Riskified Analyst Ratings

Benzinga ·  Oct 23, 2023 15:55
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/23/2023 32.98% Piper Sandler $7 → $5 Maintains Overweight
08/16/2023 99.47% Truist Securities → $7.5 Reiterates Buy → Buy
08/16/2023 86.17% Piper Sandler $8 → $7 Maintains Overweight
07/13/2023 46.28% Goldman Sachs $6 → $5.5 Maintains Neutral
05/18/2023 99.47% Credit Suisse $8 → $7.5 Maintains Outperform
05/17/2023 112.77% Piper Sandler → $8 Reiterates Overweight → Overweight
04/13/2023 46.28% Goldman Sachs $5 → $5.5 Maintains Neutral
03/10/2023 112.77% Piper Sandler $6 → $8 Upgrades Neutral → Overweight
02/24/2023 112.77% Credit Suisse $9 → $8 Maintains Outperform
02/24/2023 59.57% Piper Sandler → $6 Reiterates → Neutral
01/20/2023 Keybanc Downgrades Overweight → Sector Weight
01/09/2023 32.98% Goldman Sachs → $5 Upgrades Sell → Neutral
11/10/2022 32.98% Goldman Sachs $4.5 → $5 Maintains Sell
11/10/2022 139.36% Credit Suisse $8 → $9 Maintains Outperform
11/10/2022 32.98% Keybanc $6 → $5 Maintains Overweight
09/26/2022 59.57% Barclays $7 → $6 Maintains Overweight
08/11/2022 112.77% Credit Suisse $8.5 → $8 Maintains Outperform
08/11/2022 32.98% Goldman Sachs $4.5 → $5 Maintains Sell
08/11/2022 59.57% Piper Sandler $5 → $6 Maintains Neutral
07/18/2022 32.98% Piper Sandler $7 → $5 Maintains Neutral
07/14/2022 19.68% Goldman Sachs $6 → $4.5 Maintains Sell
07/07/2022 59.57% Keybanc $7 → $6 Maintains Overweight
05/23/2022 86.17% Barclays $8 → $7 Maintains Overweight
05/18/2022 165.96% Credit Suisse $12 → $10 Maintains Outperform
05/18/2022 86.17% Piper Sandler $10 → $7 Maintains Neutral
04/08/2022 72.87% Goldman Sachs $7 → $6.5 Maintains Sell
02/24/2022 219.15% Credit Suisse $18 → $12 Maintains Outperform
02/24/2022 165.96% Piper Sandler $14 → $10 Maintains Neutral
02/22/2022 272.34% Truist Securities $23 → $14 Maintains Buy
01/14/2022 165.96% Keybanc $18 → $10 Maintains Overweight
01/12/2022 272.34% Piper Sandler $17 → $14 Maintains Neutral
12/10/2021 139.36% Goldman Sachs → $9 Initiates Coverage On → Sell
11/17/2021 485.11% Credit Suisse $34 → $22 Maintains Outperform
11/02/2021 564.89% Keybanc $35 → $25 Maintains Overweight
08/23/2021 William Blair Initiates Coverage On → Outperform
08/23/2021 830.85% Truist Securities → $35 Initiates Coverage On → Buy
08/23/2021 777.66% Barclays → $33 Initiates Coverage On → Overweight
08/23/2021 671.28% JP Morgan → $29 Initiates Coverage On → Neutral
08/23/2021 777.66% Credit Suisse → $33 Initiates Coverage On → Outperform
08/23/2021 830.85% Keybanc → $35 Initiates Coverage On → Overweight
08/23/2021 751.06% Piper Sandler → $32 Initiates Coverage On → Overweight

What is the target price for Riskified (RSKD)?

The latest price target for Riskified (NYSE: RSKD) was reported by Piper Sandler on October 23, 2023. The analyst firm set a price target for $5.00 expecting RSKD to rise to within 12 months (a possible 32.98% upside). 15 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Riskified (RSKD)?

The latest analyst rating for Riskified (NYSE: RSKD) was provided by Piper Sandler, and Riskified maintained their overweight rating.

When is the next analyst rating going to be posted or updated for Riskified (RSKD)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Riskified, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Riskified was filed on October 23, 2023 so you should expect the next rating to be made available sometime around October 23, 2024.

Is the Analyst Rating Riskified (RSKD) correct?

While ratings are subjective and will change, the latest Riskified (RSKD) rating was a maintained with a price target of $7.00 to $5.00. The current price Riskified (RSKD) is trading at is $3.76, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment